Clinical Trial Update: Zoledronate for Osteopenia in Pediatric Crohn's [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronate for osteopenia in pediatric Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Osteopenia
• Osteoporosis

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Crohn's Disease, Osteopenia | Phase 3 | Status: COMPLETED